Imuldosa (ustekinumab-srlf) is the fifth ustekinumab biosimilar referencing Stelara to receive regulatory approval in the US.

Ticiana Leal, MD, Winship Cancer Institutes, explains the importance of biomarker testing and multidisciplinary conversations while caring for patients with early-stage non–small cell lung cancer ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Vold, MD, PhD, a senior consultant and leader of inflammatory and fibrotic research area at Oslo University Hospital, discusses therapies and management guidelines for patients with interstitial lung ...

An August 2024 update to the National Comprehensive Cancer Network (NCCN) clinical practice guidelines for treatment of ...

Here are 5 key points for pre–breast screening preparation that cover the areas of risk assessment, lifestyle adjustments, ...

Patients with endocrine-resistant, HER2-negative, locally advanced or metastatic breast cancer can use the treatment after ...

Outcomes of interest in this study were time from diagnosis to initial prescription fill for an oral multiple myeloma (MM) ...

An integrated, rule-based informatics system demonstrated its capacity to leverage electronic health records to streamline ...

The study is among the first to look at the potential impacts of clonal dynamics on patients with lower-risk myelodysplastic ...

Harrington Hospital reduced 30-day readmissions for congestive heart failure by 50% using artificial intelligence and remote ...

Vice President Kamala Harris announced her proposal that would require Medicare to cover costs of long-term home care, which ...